company background image
A950200 logo

Psomagen KOSDAQ:A950200 Stock Report

Last Price

₩4.00k

Market Cap

₩76.9b

7D

-3.6%

1Y

-21.6%

Updated

28 Dec, 2024

Data

Company Financials

A950200 Stock Overview

Engages in the provision of multi-omics solutions for clinical and research purposes. More details

A950200 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Psomagen, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Psomagen
Historical stock prices
Current Share Price₩4,000.00
52 Week High₩6,700.00
52 Week Low₩3,765.00
Beta0.10
1 Month Change-6.32%
3 Month Change-13.42%
1 Year Change-21.57%
3 Year Change-55.01%
5 Year Changen/a
Change since IPO-73.51%

Recent News & Updates

Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

Aug 28
Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

Jul 05
A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

Recent updates

Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

Aug 28
Companies Like Psomagen (KOSDAQ:950200) Are In A Position To Invest In Growth

A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

Jul 05
A Look At The Fair Value Of Psomagen, Inc. (KOSDAQ:950200)

We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Jan 13
We're Not Very Worried About Psomagen's (KOSDAQ:950200) Cash Burn Rate

Shareholder Returns

A950200KR BiotechsKR Market
7D-3.6%-0.004%-0.04%
1Y-21.6%8.4%-12.2%

Return vs Industry: A950200 underperformed the KR Biotechs industry which returned 8.4% over the past year.

Return vs Market: A950200 underperformed the KR Market which returned -12.2% over the past year.

Price Volatility

Is A950200's price volatile compared to industry and market?
A950200 volatility
A950200 Average Weekly Movement5.7%
Biotechs Industry Average Movement8.8%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.4%

Stable Share Price: A950200 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A950200's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200492n/awww.psomagen.com

Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and proteomics, a study of all the expressed proteins in an organism (proteome). It also offers Bioinformatics, a software tool and pipeline that helps scientists in analyzing data, as well as provides clinical testing solutions.

Psomagen, Inc. Fundamentals Summary

How do Psomagen's earnings and revenue compare to its market cap?
A950200 fundamental statistics
Market cap₩76.94b
Earnings (TTM)-₩6.04b
Revenue (TTM)₩38.14b

2.0x

P/S Ratio

-12.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A950200 income statement (TTM)
Revenue₩38.14b
Cost of Revenue₩30.36b
Gross Profit₩7.79b
Other Expenses₩13.82b
Earnings-₩6.04b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-313.75
Gross Margin20.42%
Net Profit Margin-15.82%
Debt/Equity Ratio2.6%

How did A950200 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 21:11
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Psomagen, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution